← Leaderboards
Tyler A Shugg
Indiana University Indianapolis
$669,059
Attributed
$669,059
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $167.3K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$669,059 · 1
By mechanism
K23$669,059 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Zeruesenay Desta$10,598,664
- Todd C. Skaar$14,016,309
- April Savoy$510,702
- Brian Scott Decker$871,664
- T. George Hornby$5,807,398
Others in their field
Other Rising Stars on “Cyp3a4 Gene”
- James N Bates · Atelerix Life Sciences Inc.$1,836,983
- Zhu Zhou · York College$794,611
- Lauren Cirrincione · University Of Washington$748,224
- Natalia Valadares De Moraes · University Of Florida$612,000
- Ronald J Biediger · Texas Heart Institute$547,028
- Yu Su · Ohio State University$417,473
Research focus
Cyp3a4 GeneAffectAdverse Event RiskAdverse EventCancer PatientCancer TherapyCareerCheckpoint TherapyCitalopramClinical DevelopmentClinically RelevantClinical ManagementClinical PracticeClinical ResearchClinical RiskClinical TrialsCollaborationsComorbidityCyp1a2 GeneCyp2b6 GeneCyp2c19 GeneCyp2c9 GeneCyp2d6 GeneCytochrome P450
Grant awards (4)
Investigation of the Immune-Mediated Drug-Drug Interaction Potential of Immune Checkpoint Inhibitors$167,256
K23 · FY2025 · GM · contact PI
Investigation of the Immune-Mediated Drug-Drug Interaction Potential of Immune Checkpoint Inhibitors$167,256
K23 · FY2024 · GM · contact PI
Investigation of the Immune-Mediated Drug-Drug Interaction Potential of Immune Checkpoint Inhibitors$167,278
K23 · FY2023 · GM · contact PI
Investigation of the Immune-Mediated Drug-Drug Interaction Potential of Immune Checkpoint Inhibitors$167,269
K23 · FY2022 · GM · contact PI